Showing results (51-60 of 74) with videos related to
Sort By:
Pageof 8
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
A signaling polypeptide derived from an innate immune adaptor molecule can be harnessed as a new class of vaccine adjuvantKouji Kobiyama, Fumihiko Takeshita, Ken J Ishii, et al.Biochemical and Biophysical Research Communications|March 24, 2023
Linking antigen specific T-cell dynamics in a microfluidic chip to single cell transcription patternsHiroki Ide, Taiki Aoshi, Masato Saito, et al.Plos One|June 3, 2014
Protective epitopes of the Plasmodium falciparum SERA5 malaria vaccine reside in intrinsically unstructured N-terminal repetitive sequencesMasanori Yagi, Gilles Bang, Takahiro Tougan, et al.Plos One|April 5, 2013
The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvantChoon Kit Tang, Taiki Aoshi, Nao Jounai, et al.Journal of Immunology Research|September 18, 2015
Development of Nonaggregating Poly-A Tailed Immunostimulatory A/D Type CpG Oligodeoxynucleotides Applicable for Clinical UseTaiki Aoshi, Yasunari Haseda, Kouji Kobiyama, et al.Nature Immunology|June 9, 2009
Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-cateninKarel Otero, Isaiah R Turnbull, Pietro Luigi Poliani, et al.Clinical and Vaccine Immunology : CVI|May 19, 2017
Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of AlphavirusAkane Urakami, Atsuko Sakurai, Momoko Ishikawa, et al.Oncotarget|July 8, 2016
Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cellsYuji Kitahata, Tomohiro Kanuma, Masayuki Hayashi, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|October 20, 2019
Lipid nanoparticles of Type-A CpG D35 suppress tumor growth by changing tumor immune-microenvironment and activate CD8 T cells in miceLisa Munakata, Yoshihiko Tanimoto, Akio Osa, et al.Tissue Barriers|May 6, 2021
HDAC inhibitor, MS-275, increases vascular permeability by suppressing Robo4 expression in endothelial cellsTaito Kashio, Keisuke Shirakura, Mayumi Kinoshita, et al.Pageof 8